Autor(es)

Manuel Munoz Lora, Victor Ricardo ; Clemente-Napimoga, Juliana Trindade ; Abdalla, Henrique Ballassini ; Macedo, Cristina Gomes ; Canales, Giancarlo de la Torre ; Rizzatti Barbosa, Celia Marisa

• Tipo de documento: Artigo Científico
• Fonte: Toxicon; v. 129, p. 52-57, APR 2017.
• Citações Web of Science: 11

Resumo

Objective: This study aimed to investigate the antinociceptive effects of Botulinum toxin type A (BoNT-A) on persistent inflammatory hypernociception induced by arthritis in the temporomandibular joint (TMJ) of rats. Material and methods: Wistar rats were induced to persistent inflammatory hypernociception in the left TMJ. Then, animals were treated with intra-TMJ injections of BoNT-A, using doses of 3.5, 7 and 14 U/kg. Saline was used as control group. Behavioral tests were applied to evaluated the effect of BoNT-A in the inflammatory hypernociception. After that, animals were euthanized and samples from peri-articular tissues and trigeminal ganglia were obtained for further analyses. Results: BoNT-A reduced the persistent inflammatory hypernociception induced by arthritis in the TMJ of rats. BoNT-A significantly reduced the peripheral release of the neurotransmitters Substance P and Calcitonin gene related peptide; and the pro-inflammatory cytokine IL-10. Otherwise, BoNT-A had no effect in the peripheral release of glutamate and the cytokine TNF-alpha. Conclusion: These results demonstrate that intra-articular injection of BoNT-A reduces the albumin induced arthritis persistent hypernociception in TMJ of rats by peripheral inhibition of neuropeptides release. 2017 Elsevier Ltd. All rights reserved. (AU)

• Processo FAPESP: 14/15863-7 - Comparação do grau de eficiência do tratamento convencional e do tratamento com TXB-A em portadores de disfunção temporomandibular miogênica e dor crônica
• Beneficiário: Celia Marisa Rizzatti Barbosa
• Modalidade de apoio: Auxílio à Pesquisa - Regular